DOR BioPharma, (DORB) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
DOR BioPharma, (DORB)

An SI Board Since April 2007

Posts	SubjectMarks	Bans	Symbol
35	2	0	DORB

Emcee: Paul Lee	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
10	DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FD	Paul Lee	-	12/7/2007
9	DOR BioPharma Announces Named Patient Access Program for orBec(R) in Collaborati	Paul Lee	-	11/28/2007
8	DOR BioPharma Receives Not Approvable Letter From FDA for orBec(R) for Treatment	Tadsamillionaire	-	10/19/2007
7	DOR BioPharma Announces Issuance of Patents for Oral Graft Versus Host Disease T	Paul Lee	-	9/25/2007
6	orBec(R) Clinical Review Published in "Expert Review of Clinical Immunology	Paul Lee	-	9/17/2007
5	Miami, FL. – August 14, 2007 - DOR BioPharma, Inc. (OTCBB: DORB) (“DOR” or the “	Paul Lee	-	8/14/2007
4	DOR BioPharma Announces $940,000 FDA Orphan Products Grant for Clinical Developm	Paul Lee	-	7/30/2007
3	DOR BioPharma, Inc. Announces Initiation of orBec(R) Phase 2 GVHD Prophylaxis Cl	Paul Lee	-	7/12/2007
2	DOR BioPharma Announces Release of Advisory Committee Briefing Documents by FDA	Paul Lee	-	5/7/2007
1	Mike W. writes, "What is your opinion on DORB? Will OrBec be approved?"	Paul Lee	-	4/22/2007

Go to reply# or date (mm/dd/yy):